RABIATU BUNDU: Open Payments
NPI 1629683503 · CAMP SPRINGS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,488 in 56 payments from 16 companies in 2025. Trend: 2023 $1,099 · 2024 $1,522 · 2025 $1,488
Food & beverage: $1,488
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $318 |
| AstraZeneca Pharmaceuticals LP | 5 | $295 |
| Lilly USA, LLC | 5 | $206 |
| ABBVIE INC. | 7 | $150 |
| PFIZER INC. | 5 | $111 |
| Novartis Pharmaceuticals Corporation | 4 | $81 |
| Gilead Sciences, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| Amgen Inc. | 2 | $41 |
| SANOFI-AVENTIS U.S. LLC | 1 | $37 |
Products named: AIRSUPRA, ZEPBOUND, Ozempic, UBRELVY, Wegovy, BREZTRI, LEQVIO, MOUNJARO.
Industry payments across MD — which companies pay providers there.
